Em Levy
- Democratic
- Representative
- District 53
Primary
Requires prescription drug manufacturers to report to the Department of Consumer and Business Services the total number of consumers to which the manufacturer offered a patient assistance program who participated in the program, notwithstanding any increase in the price of the prescription drug for which the manufacturer offered the program.
In committee upon adjournment.
Motion to rerefer to Behavioral Health and Health Care carried. Rereferred.
Rules suspended. Carried over to April 9, 2025 Calendar.
Second reading.
Recommendation: Do pass.
Work Session held.
Public Hearing held.
Referred to Behavioral Health and Health Care.
First reading. Referred to Speaker's desk.
| Bill Text Versions | Format |
|---|---|
| Introduced |
| Document | Format |
|---|---|
| No related documents. |
Data on Open States is updated periodically throughout the day from the official website of the Oregon Legislative Assembly.
If you notice any inconsistencies with these official sources, feel free to file an issue.